2,2'-azobis(2-amidinopropane) has been researched along with Hyperlipidemias in 3 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lovastatin treatment did not significantly affect the antioxidant capacity of LDL." | 2.69 | Comparison of LDL trap assay to other tests of antioxidant capacity; effect of vitamin E and lovastatin treatment. ( Malminiemi, K; Malminiemi, O; Palomäki, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kontush, A | 2 |
| Reich, A | 2 |
| Baum, K | 1 |
| Spranger, T | 2 |
| Finckh, B | 2 |
| Kohlschütter, A | 2 |
| Beisiegel, U | 2 |
| Djahansouzi, S | 1 |
| Karten, B | 1 |
| Braesen, JH | 1 |
| Malminiemi, K | 1 |
| Palomäki, A | 1 |
| Malminiemi, O | 1 |
1 trial available for 2,2'-azobis(2-amidinopropane) and Hyperlipidemias
| Article | Year |
|---|---|
Comparison of LDL trap assay to other tests of antioxidant capacity; effect of vitamin E and lovastatin treatment.
Topics: Amidines; Anticholesteremic Agents; Antioxidants; Copper Sulfate; Coronary Disease; Cross-Over Studi | 2000 |
2 other studies available for 2,2'-azobis(2-amidinopropane) and Hyperlipidemias
| Article | Year |
|---|---|
Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia.
Topics: Adult; Alcohol Drinking; Amidines; Antidotes; Body Mass Index; Coronary Disease; Female; Humans; Hyp | 1997 |
Whole plasma oxidation assay as a measure of lipoprotein oxidizability.
Topics: Amidines; Animals; Antioxidants; beta Carotene; Carotenoids; Copper; Fatty Acids, Nonesterified; Hum | 1997 |